Literature DB >> 11443069

Inhibition of TASK-1 potassium channel by phospholipase C.

G Czirják1, G L Petheo, A Spät, P Enyedi.   

Abstract

The two-pore-domain K(+) channel, TASK-1, was recently shown to be a target of receptor-mediated regulation in neurons and in adrenal glomerulosa cells. Here, we demonstrate that TASK-1 expressed in Xenopus laevis oocytes is inhibited by different Ca(2+)-mobilizing agonists. Lysophosphatidic acid, via its endogenous receptor, and ANG II and carbachol, via their heterologously expressed ANG II type 1a and M(1) muscarinic receptors, respectively, inhibit TASK-1. This effect can be mimicked by guanosine 5'-O-(3-thiotriphosphate), indicating the involvement of GTP-binding protein(s). The phospholipase C inhibitor U-73122 reduced the receptor-mediated inhibition of TASK-1. Downstream signals of phospholipase C action (inositol 1,4,5-trisphosphate, cytoplasmic Ca(2+) concentration, and diacylglycerol) do not mediate the inhibition. Unlike the G(q)-coupled receptors, stimulation of the G(i)-activating M(2) muscarinic receptor coexpressed with TASK-1 results in an only minimal decrease of the TASK-1 current. However, additional coexpression of phospholipase C-beta(2) (which is responsive also to G(i) beta gamma-subunits) renders M(2) receptor activation effective. This indicates the significance of phospholipase C activity in the receptor-mediated inhibition of TASK-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443069     DOI: 10.1152/ajpcell.2001.281.2.C700

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  40 in total

1.  IKCa1 activity is required for cell shrinkage, phosphatidylserine translocation and death in T lymphocyte apoptosis.

Authors:  James I Elliott; Christopher F Higgins
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

Review 2.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

3.  Covalent modification of a volatile anesthetic regulatory site activates TASK-3 (KCNK9) tandem-pore potassium channels.

Authors:  Kevin E Conway; Joseph F Cotten
Journal:  Mol Pharmacol       Date:  2011-12-06       Impact factor: 4.436

4.  Convergent and reciprocal modulation of a leak K+ current and I(h) by an inhalational anaesthetic and neurotransmitters in rat brainstem motoneurones.

Authors:  Jay E Sirois; Carl Lynch; Douglas A Bayliss
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

5.  Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus.

Authors:  Jaehee Han; Carmen Gnatenco; Celia D Sladek; Donghee Kim
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

6.  Characterization of four types of background potassium channels in rat cerebellar granule neurons.

Authors:  Jaehee Han; Jeffrey Truell; Carmen Gnatenco; Donghee Kim
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

7.  Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels.

Authors:  Jean Chemin; Christophe Girard; Fabrice Duprat; Florian Lesage; Georges Romey; Michel Lazdunski
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 8.  The 2P-domain K+ channels: role in apoptosis and tumorigenesis.

Authors:  Amanda J Patel; Michel Lazdunski
Journal:  Pflugers Arch       Date:  2004-05-05       Impact factor: 3.657

9.  PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors.

Authors:  Alessandra Matavel; Coeli M B Lopes
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

10.  A phospholipid sensor controls mechanogating of the K+ channel TREK-1.

Authors:  Jean Chemin; Amanda Jane Patel; Fabrice Duprat; Inger Lauritzen; Michel Lazdunski; Eric Honoré
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.